Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beijing Tiantan Biological Products 3-Year ROIIC %?
Beijing Tiantan Biological ProductsSHSE:600161 69 3-Year ROIIC % is 7.84 as of Dec. 2025, which is 12% above its 10-year median of 7.01. GuruFocus rates SHSE:600161 with a GF Score™ of 69/100 and a GF Value™ of ¥22.96 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,320 Biotechnology companies, Beijing Tiantan Biological Products ranks better than 60.08% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Beijing Tiantan Biological Products's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 7.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Beijing Tiantan Biological Products 3-Year ROIIC % Related Terms
Beijing Tiantan Biological Products 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600161 vs VRTX, REGN, RVMD: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Beijing Tiantan Biological Products's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tiantan Biological Products 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Beijing Tiantan Biological Products's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Beijing Tiantan Biological Products (SHSE:600161) has a 3-Year ROIIC % of 7.84 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Beijing Tiantan Biological Products and its competitors. This is 12% above median its historical median of 7.01. According to the industry distribution chart, Beijing Tiantan Biological Products ranks #527 out of 1320 companies in the Biotechnology industry, placing it in the top 39.9%.
Is Beijing Tiantan Biological Products' 3-Year ROIIC % too high?
Beijing Tiantan Biological Products' current 3-Year ROIIC % of 7.84 is 12% above median its 10-year median of 7.01. Based on the distribution chart, Beijing Tiantan Biological Products ranks #527 out of 1320 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Tiantan Biological Products has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tiantan Biological Products ranks #527 out of 1320 companies for 3-Year ROIIC %. This puts Beijing Tiantan Biological Products in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Beijing Tiantan Biological Products and its competitors. Beijing Tiantan Biological Products's current 3-Year ROIIC % is 7.84, which is 12% above median its own 10-year median of 7.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥22.96, compared to a current price of ¥12.83 — trading 44.1% below its estimated fair value. The current 3-Year ROIIC % is 7.84, which is 12% above median its 10-year median of 7.01. Beijing Tiantan Biological Products' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current 3-Year ROIIC % is 7.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued.
The current stock price of ¥12.83 is trading 44.1% below its estimated GF Value™ of ¥22.96.
GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.
Key valuation signals for SHSE:600161:
3-Year ROIIC %: 7.84 (12% above median its 10-year median of 7.01)
GF Value™: ¥22.96 vs. price of ¥12.83 (44.1% below fair value)
No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
69GF Score
Get the complete analysis for SHSE:600161
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600161 has been successfully added to your 
